Search Tag: antibiotic treatment


2023 02 May

Dr François Ventura, anaesthesiologist and intensive care physician, gave a lecture on the " C urrent research on sepsis biomarkers and early diagnosis"  during the 4th World Sepsis Congress, organised by the Global Sepsis Alliance, which took place the 25 th and 26 th April 2023. He discussed the challenges of diagnosing sepsis, which requires...Read more

ICU Management

2022 14 Oct

Severe infections by antibiotic resistant gram-negative bacteria are frequent in ICU patients. They are associated with high morbidity and mortality. Introduction Bacterial infections in patients hospitalised in the Intensive Care Unit (ICU) are frequent, and they elicit an increase in morbidity and mortality. The emerging development...Read more

ICU Management

2018 03 Jul

The incidence of sepsis – a condition that is associated with high morbidity and mortality – seems to be increasing. Early appropriate antibiotic treatment is essential to improve survival. Researchers in Spain say that despite advances in sepsis treatment in recent years, educational interventions can still improve the delivery of care.  Further...Read more

ICU Management

2018 06 Feb

Using biomarkers as a guide to tailor the duration of antibiotic treatment in respiratory infections is an attractive hypothesis assessed in several studies. However, after more than a decade of randomised controlled trials on procalcitonin (PCT)-guided antibiotic treatment, the evidence favouring PCT use is still less than compelling due to limitations...Read more

ICU Management

2017 22 Mar

The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use...Read more

Executive Health Management

2015 12 Jun

According to researchers at the University of Virginia School of Medicine and 22 other institutions, the duration of antibiotic treatment for complicated abdominal infections can be cut by half and still remain effective. This could play an important role in preventing the development of antibiotic-resistant superbugs. The research team looked at...Read more